These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11782542)

  • 1. Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?
    Havlir DV
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):4-6. PubMed ID: 11782542
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS. Boosting immunity to HIV--can the virus help?
    Autran B; Carcelain G
    Science; 2000 Nov; 290(5493):946-9. PubMed ID: 11184735
    [No Abstract]   [Full Text] [Related]  

  • 3. The emerging race to cure HIV infections.
    Cohen J
    Science; 2011 May; 332(6031):784-5, 787-9. PubMed ID: 21566173
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV neutralizing antibodies reignite interest in vaccine.
    Waltz E
    Nat Biotechnol; 2012 Mar; 30(3):204-5. PubMed ID: 22398603
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic HIV vaccines show promise.
    Abbott A
    Nature; 2010 Jul; 466(7306):539. PubMed ID: 20671679
    [No Abstract]   [Full Text] [Related]  

  • 6. IL-2 immunotherapy does not benefit patients taking antiretrovirals.
    AIDS Patient Care STDS; 2009 Mar; 23(3):221-2. PubMed ID: 19866543
    [No Abstract]   [Full Text] [Related]  

  • 7. Cure of HIV infection: is the long wait over?
    Shearer WT
    J Allergy Clin Immunol; 2014 Jul; 134(1):20-2. PubMed ID: 25117800
    [No Abstract]   [Full Text] [Related]  

  • 8. The need for novel targets and approaches to HIV therapy.
    Martinez LJ
    Res Initiat Treat Action; 2002; 8(1):23-5. PubMed ID: 12489523
    [No Abstract]   [Full Text] [Related]  

  • 9. Can immune systems be trained to fight HIV?
    Balter M
    Science; 1999 Nov; 286(5444):1470-11. PubMed ID: 10610544
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
    Barta SK; Samuel MS; Xue X; Wang D; Lee JY; Mounier N; Ribera JM; Spina M; Tirelli U; Weiss R; Galicier L; Boue F; Little RF; Dunleavy K; Wilson WH; Wyen C; Remick SC; Kaplan LD; Ratner L; Noy A; Sparano JA
    Ann Oncol; 2015 May; 26(5):958-966. PubMed ID: 25632071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 count/viral load in HIV.
    Hengel R
    Cytometry; 2000 Feb; 42(1):79-80. PubMed ID: 10679747
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of the SILCAAT and ESPRIT trials and the future for HIV immunotherapy.
    Peters BS; Samuel M
    J HIV Ther; 2010 Mar; 15(1):15-7. PubMed ID: 21180234
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic strategies against HIV: status in 1994 and future prospectives].
    Internist (Berl); 1994 Jul; 35(7 Suppl):1-24. PubMed ID: 9131074
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive clinical care: managing HIV as a chronic illness.
    Reiter GS
    AIDS Clin Care; 2000 Feb; 12(2):13-9. PubMed ID: 12170963
    [No Abstract]   [Full Text] [Related]  

  • 15. CYT107 enters Phase II clinical trial in HIV-infected patients.
    Immunotherapy; 2010 Nov; 2(6):755. PubMed ID: 21091106
    [No Abstract]   [Full Text] [Related]  

  • 16. Selected topics from the 10th Conference on Retroviruses and Opportunistic Infections.
    Dybul M
    HIV Clin Trials; 2003; 4(4):282-6. PubMed ID: 12916014
    [No Abstract]   [Full Text] [Related]  

  • 17. HAART and host: balancing the response to HIV-1. Highly active antiretroviral therapy.
    Morris K
    Lancet; 1998 Nov; 352(9141):1686. PubMed ID: 9853453
    [No Abstract]   [Full Text] [Related]  

  • 18. The ethics of research in developing countries.
    Greco DB
    N Engl J Med; 2000 Aug; 343(5):362; author reply 363. PubMed ID: 10928889
    [No Abstract]   [Full Text] [Related]  

  • 19. AmFAR HIV/AIDS treatment directory available.
    AIDS Treat News; 2001 Mar; (362):8. PubMed ID: 11569958
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vaccines, molecular scissors, fusion inhibitors. What does HIV therapy of the future look like?].
    Warpakowski A
    MMW Fortschr Med; 2009 Nov; 151(46):22-3. PubMed ID: 20043388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.